Category - New Drugs
UCB Announces the Approval of Cimzia (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis
FDA Approves Palynziq (pegvaliase-pqpz) for the Treatment of Adults with Phenylketonuria
GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age
Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer
Lilly’s Taltz (ixekizumab) Receives the First U.S. FDA Approval for Label Update to Include Data for Psoriasis Involving the Genital Area
FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure
FDA Approves Prolia (denosumab) for Glucocorticoid-Induced Osteoporosis
FDA Approves Lokelma (sodium zirconium cyclosilicate) for the Treatment of Adults with Hyperkalemia